# Vericel Corporation - Inspection Records

Source: https://www.keypedia.com/companies/vericel-corporation/1955c523-5115-491b-a705-2c526deb9ff6

> Inspection records and compliance data for Vericel Corporation in Cambridge, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Vericel Corporation
- FEI Number: 3002836339
- City: Cambridge
- State: Massachusetts
- Country Name: United States
- Address Line 1: 64 Sidney St
- Zip Code: 02139

## Related Documents

- [483 - Vericel Corporation - 2026-06-12](https://www.keypedia.com/records/483/vericel-corporation/a6cf0044-e8d4-43f4-9a80-0b7df538c8c3) — source: FDA, date: June 12, 2026
- [FDA Inspection 1322008 - Vericel Corporation - 2026-06-12](https://www.keypedia.com/records/fda_inspections/vericel-corporation/8875f433-1868-4cd9-80b6-522a7c9d8a47) — source: FDA, date: June 12, 2026
- [FDA Inspection 1322008 - Vericel Corporation - 2026-06-12](https://www.keypedia.com/records/fda_inspections/vericel-corporation/02e881c9-9b82-410c-b598-43e33c6e9d99) — source: FDA, date: June 12, 2026
- [483 - Vericel Corporation - 2024-09-25](https://www.keypedia.com/records/483/vericel-corporation/591494ca-ea68-4c12-931e-e1bbc21a02be) — source: FDA, date: September 25, 2024
- [483 - Vericel Corporation - 2024-09-25](https://www.keypedia.com/records/483/vericel-corporation/7ef5bcce-bff7-43be-a086-a663c995e318) — source: FDA, date: September 25, 2024
- [FDA Inspection 1249999 - Vericel Corporation - 2024-09-25](https://www.keypedia.com/records/fda_inspections/vericel-corporation/80748f57-90fb-4dfc-b364-f1fc33a7472d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 25, 2024
- [FDA Inspection 1249999 - Vericel Corporation - 2024-09-25](https://www.keypedia.com/records/fda_inspections/vericel-corporation/14fd491e-b3d9-4240-a85a-736a89e99616) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 25, 2024
- [FDA Inspection 1249999 - Vericel Corporation - 2024-09-25](https://www.keypedia.com/records/fda_inspections/vericel-corporation/c1d5cb74-391c-466b-940d-5bb2d82fe428) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 25, 2024
- [FDA Inspection 1249999 - Vericel Corporation - 2024-09-25](https://www.keypedia.com/records/fda_inspections/vericel-corporation/7bb4e8cb-19d0-4d4a-bb68-028b546f29da) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 25, 2024
- [483 - Vericel Corporation - 2023-07-21](https://www.keypedia.com/records/483/vericel-corporation/e1d22958-7161-4349-b22f-265b47f366d9) — source: FDA, date: July 21, 2023
- [FDA Inspection 1210597 - Vericel Corporation - 2023-07-21](https://www.keypedia.com/records/fda_inspections/vericel-corporation/b6697f78-5c18-4b52-b12d-acb5f892368c) — classification: No Action Indicated (NAI), source: FDA, date: July 21, 2023
- [FDA Inspection 1210597 - Vericel Corporation - 2023-07-21](https://www.keypedia.com/records/fda_inspections/vericel-corporation/b4618a5a-85fd-4b90-8285-283f78ad4cac) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2023
- [FDA Inspection 1006746 - Vericel Corporation - 2016-05-27](https://www.keypedia.com/records/fda_inspections/vericel-corporation/1668f1af-ae4d-4b66-875a-102907b241d9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 27, 2016
- [FDA Inspection 870615 - Vericel Corporation - 2014-03-19](https://www.keypedia.com/records/fda_inspections/vericel-corporation/7eced8fe-ebad-49e9-bf61-8ced66f80d1c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 19, 2014

## Related Companies

- [Anhui Poly Pharm. Co., Ltd.](https://www.keypedia.com/companies/anhui-poly-pharm-co-ltd/e1d9c61f-37b4-4759-8c00-51c6d0b78d3b)
- [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)
- [Advanced Accelerator Applications (Italy) srl](https://www.keypedia.com/companies/advanced-accelerator-applications-italy-srl/09ac059c-6735-4082-8674-a88476dbdbc6)
- [OMRIX Biopharmaceuticals LTD](https://www.keypedia.com/companies/omrix-biopharmaceuticals-ltd/bf1b8f1e-b1c7-47be-bb38-f85e1cff944d)
- [AgroChem USA, LLC](https://www.keypedia.com/companies/agrochem-usa-llc/007b3455-bf3c-4d23-b1e7-0be79ebba21e)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)
- [Merck Sharp & Dohme LLC](https://www.keypedia.com/companies/merck-sharp-dohme-llc/842c6e25-ee89-453c-a5b0-6b039c187744)
- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [New York Blood Center Enterprises](https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db)
- [Reliance Life Sciences Private Limited](https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f)

## Related Officers

- [Nancy G Berger](https://www.keypedia.com/people/nancy-g-berger/004896a3-d50d-45f1-bb46-36f9bbe4bdb5)
- [Laurel A. Beer](https://www.keypedia.com/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e)
- [investigator](https://www.keypedia.com/people/james-p-finn/70e5c36c-2711-449b-bf73-e08b4dd58449)